Implications for future pandemics from a living systematic review and critical evaluation of observational studies of the effectiveness of COVID-19 vaccination against the Omicron variant.
Fatema Kazi, Chin Yang Shapland, Francesca Spiga et al.
✦ AI-curated · Sources linked
In 30 seconds
This living systematic review evaluated the effectiveness of COVID-19 vaccines against the Omicron variant, analyzing 79 observational studies involving over 53 million individuals. The review found that vaccination significantly reduced the risk of severe or critical COVID-19, particularly with mRNA vaccines, with an effectiveness estimate of 67.1%. The study highlights the need for improved methodologies in future pandemic research.
Key findings
- Vaccination showed 67.1% effectiveness against severe or critical COVID-19 caused by the Omicron variant.
- The review included 79 studies with over 53 million individuals contributing 2032 effectiveness estimates.
- Most results were assessed as having moderate (18%) or serious (78%) risk of bias.
- Standardized study protocols and robust data linkage are crucial for future pandemic preparedness.
Why it matters
Understanding vaccine effectiveness against emerging variants like Omicron is critical for shaping public health strategies and vaccination campaigns. This review provides essential insights into the protective benefits of vaccination, particularly for severe disease outcomes.